Increased potency of an aptameric G-rich oligonucleotide is associated with novel functional properties of phosphorothioate linkages

Antisense and Nucleic Acid Drug Development

Volumn 9, Issue 3, 1999, Pages 289-300

  Tam, Robert C ^a   Wu Pong, Susanna ^b   Pai, Bharati ^a   Lim, Charmaine ^a   Chan, Amy ^b   Thomas, Diana F ^b   Milovanovic, Tatjana ^a   Bard, Josie ^a   Middleton, Patrick J ^a  

^a Valeant Pharmaceuticals International   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CONTACT ALLERGEN; OLIGODEOXYNUCLEOTIDE; PHOSPHOROTHIOIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTACT ALLERGY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; NORMAL HUMAN; OTITIS; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE;

EID: 0032788026     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1999.9.289     Document Type: Article

References (18)

1. AKHTAR, S., KOLE, R., and JULIANO, R.L. (1991). Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci. 49, 1793-1801.
2. BISHOP, J.S., GUY-CAFFEY, J.K., OJWANG, J.O., SMITH, S.R., HOGAN, M.E., COSSUM, P.A., RANDO, R.F., and CHAUDHARY, N. (1996). Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide. J. Biol. Chem. 271, 5698-5703.
3. BLACK, L.E., FARRELLY, J.G., CAVAGNARO, J.A., AHN, C.H., DEGEORGE, J.J., TAYLOR, A.S., DEFELICE, A.F., and JORDAN, A. (1994). Regulatory considerations for oligonucleotide drugs: Updated recommendations for pharmacology and toxicology studies. Antisense Res. Dev. 4, 299-301.
4. BROWN, D.A., KANG, S.H., GRYAZNOV, S.M., DEDIONISIO, L., HEIDENREICH, O., SULLIVAN, S., XU, X., and NERENBERG, M.I. (1994). Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem. 269, 26801-26805.
5. CAMPBELL, J.M., BACON, T.A, and WICKSTROM, E. (1990). Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid. J. Biochem. Biophys. Methods 20, 259-267.
6. CARUTHERS, M.H., BARONE, A.D., BEAUCAGE, S.L., DODDS, D.R., FISHER, E.F., McBRIDE, L.J., MATTEUCCI, M., STABINSKY, Z., and TANG, J.Y. (1987). Chemical synthesis of deoxyoligonucleotides by the phosphoramidite method. Methods Enzymol. 154, 287-313.
7. HOKE, G.D., DRAPER, K., FREIER, S.M., GONZALEZ, C., DRIVER, V.B., ZOUNES, M.C., and ECKER, D.J. (1991). Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucleic Acids Res. 19, 5743-5748.
8. HUGHES, J.A., AVRUTSKAYA, A.V., and JULIANO, R.L. (1994). Influence of base composition on membrane binding and cellular uptake of 10-mer phosphorothioate oligonucleotides in Chinese hamster ovary (CHRC5) cells. Antisense Res. Dev. 4, 211-215.
9. LENSCHOW, D.J., ZENG, Y., THISTLETHWAITE, J.R., MONTAG, A., BRADY, W., GIBSON, M.G., LINSLEY, P.S., and BLUESTONE, J.A. (1992). Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257, 789-792.
10. LINSLEY, P.S., and LEDBETTER, J.A. (1993). The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11, 191-212.
11. PISETSKY, D.S., and REICH, C.F. (1994). Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus. Life Sci. 54, 101-107.
12. REISER, H., and SCHNEEBERGER, E.E. (1996). Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity. Eur. J. Immunol. 26, 880-885.
13. SMITH, F.W., and FEIGON, J. (1993). Strand orientation in the DNA quadruplex formed from the Oxytricha telomere repeat oligonucleotide d(G4T4G4) in solution. Biochemistry 32, 8682-8692.
14. STEIN, C.A. (1995). Does antisense exist? Nat. Med. 1, 1119-1121.
15. STEIN, C.A., and COHEN, J.S. (188). Oligodeoxynucleotides as inhibitors of gene expression: A review. Cancer Res. 48, 2659-2668.
16. STEIN, C.A., SUBASINGHE, C., SHINOZUKA, K., and COHEN, J.S. (1988). Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 16, 3209-3221.
17. TAM, R.C., LI, Y., NOONBERG, S., HWANG, D.G., LUI, G., HUNT, C.A., and GARAVOY, M.R. (1994). Biological availability and nuclease resistance extend the in vitro activity of a phosphorothioate-3′ hydroxypropylamine oligonucleotide. Nucleic Acids Res. 22, 977-986.
18. ZHAO, Q., TEMSAMANI, J., IADAROLA, P.L., JIANG, Z., and AGRAWAL, S. (1996).Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem. Pharmacol. 51, 173-182.